Distribution International Company's Crossroads C&I completed its acquisition of GlassCell Isofab. Based in Toronto, GlassCell Isofab distributes and fabricates products for thermal and acoustical insulation. It operates from central and eastern Canada in nine locations.
Former Vice President for Sales and Marketing at GlassCell Isofab, and now newly-acquired firm's Regional Director of Central and Eastern Canada Bob Fellows, viewed the sale as beneficial for all concerned. "This acquisition is a positive outcome for our employees, customers, and vendors. In joining Crossroads, a Distribution International Company, we will be able to expand our product offering, geographic footprint, and fabrication capabilities while maintaining the standards of service that our customers have come to expect," he said.
A portfolio company of Audax Private Equity and The CapStreet Group, Distribution International is headquartered in Texas. It distributes insulation and fabricated products and safety supply equipment to various end markets in the industrial, commercial, and marine sectors. Distribution International's CEO Celeste Mastin considers GlassCell Isofab as a great addition to their company.
Join the Conversation